Author: Steve Hackney

Reliv International, Inc (NASDAQ:RELV) CardioSentials Heart Health Supplement Gets Patent
Health

Reliv International, Inc (NASDAQ:RELV) CardioSentials Heart Health Supplement Gets Patent

Reliv International, Inc (NASDAQ:RELV) reported that CardioSentials® heart health supplement has obtained a U.S. patent. The company first shared the success with the firm’s distributors through a podcast showcasing Dr. Carl Hastings, the Chief Scientific Officer and also the product’s creator. The details CardioSentials’ patented formula comprises ingredients demonstrated to […]

Greengro Technologies Inc (OTCMKTS:GRNH) Signs $25 Million Smart Greenhouse Franchise Deal
Technology

Greengro Technologies Inc (OTCMKTS:GRNH) Signs $25 Million Smart Greenhouse Franchise Deal

Greengro Technologies Inc (OTCMKTS:GRNH) a renowned provider of eco-friendly green know-how reported that it has a finalized a definitive deal on a 10-acre, $25 million hydroponic indoor farm assignment with Global Renewable Resources, LLC, Shaker Heights, Ohio, a startup specializing in renewable energy and sustainable technologies. The details The deal […]

Media Giants Partnered With Giants Like Facebook Inc (NASDAQ:FB) Are Not Achieving The Results That Was Promised
Technology

Media Giants Partnered With Giants Like Facebook Inc (NASDAQ:FB) Are Not Achieving The Results That Was Promised

It is well-known that large media corporations have partnered up with social-media giants such as Facebook Inc. (NADAQ:FB), and Snapchat is not achieving the lucrative results, which seemed promising upon the initial partnership agreement. These partnerships between news entities and social media giants are namely performed due to the concern […]

Delcath Systems, Inc. (NASDAQ:DCTH) Melphalan / HDS Medicinal Treatment Has Been Accepted For Oral Presentation
Advancers

Delcath Systems, Inc. (NASDAQ:DCTH) Melphalan / HDS Medicinal Treatment Has Been Accepted For Oral Presentation

It was recently announced that clinical medicine, Melphalan/HDS, which was manufactured by Delcath Systems, Inc. (NADAQ:DCTH) has been accepted for oral presentation. The medicine in question was manufactured, with the specific purpose of treatment for Unresectable Metastatic Ocular Melanoma. This entity is responsible for delivering medical mechanisms, which focus primarily […]